Vistra Corp. enters its May 5 Q1 report with short sellers pressing harder — but the borrow market suggests they're fishing in a deep pool.
Short interest jumped 24% in a single week to 3.3% of the free float, a 29% rise month-on-month that takes positions back to their highest level in at least a month. That acceleration looks deliberate: bears added aggressively in the week beginning April 23, after a period of relative stability. Yet the borrow market is nowhere near strained. Cost to borrow is running at 0.28% APR — down 23% on the week. Availability remains extremely loose, with the borrow pool far from exhausted and well below even a fraction of its 52-week peak in tightness. This is not a setup where short sellers are fighting for scarce stock; they're building positions cheaply, in size.
Options positioning reinforces a cautious lean without signalling outright alarm. The put/call ratio is 1.52, modestly above its 20-day average of 1.47 and a z-score just under 0.5 standard deviations from the mean — elevated but not extreme relative to VST's own history. The stock has traded with a persistently hedged options market for weeks; this is close to a structural feature of a high-beta power stock rather than a specific pre-earnings panic. The stock itself is down 5.5% over the past week to $155.28, a pullback that comes on top of a still-positive one-month gain of 3.3%. The RSI sits near 49, offering no directional conviction from technicals.
The analyst community remains firmly constructive on valuation grounds, even as individual price targets drift lower. JP Morgan's Jeremy Tonet trimmed his Overweight target from $240 to $231 on April 30 — the day before the data snapshot — but kept the positive rating. The consensus price target runs at $229.63, implying roughly 45% upside to current levels, a gap that reflects how far the stock has retreated from prior highs. The bull case rests on the Cogentrix acquisition lifting EBITDA estimates by around 7%, a free cash flow conversion target at or above 60% of adjusted EBITDA from 2026 onward, and expanding retail margins. Bears counter with a different reading of the same period: the stock is already down roughly 30% from its peak, and VST has absorbed an estimated $1.6 billion adverse EBITDA impact from commodity price volatility and high fuel procurement costs. EPS forward momentum scores in the 80th percentile on a 30-day basis, a sharp divergence from the 24th percentile on the 90-day view — suggesting the positive estimate trend is recent and concentrated, not a sustained re-rating.
Insider selling adds one more layer of context. In late February and early March, virtually the entire C-suite — CEO James Burke, CFO Kris Moldovan, the Chief Strategy Officer, Chief Compliance Officer, and others — sold stock at prices in the $167–$172 range, well above Friday's close of $155.28. Net insider sales over the 90-day window totalled over $223 million in value. That doesn't signal panic, but it does mean the people closest to operations were trimming at prices the stock has since failed to hold. The print on May 5 is therefore less about whether Vistra can grow and more about whether Q1 margin delivery — in the face of those commodity headwinds — is enough to close the gap between where the stock trades and where analysts say it belongs.
See the live data behind this article on ORTEX.
Open VST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
